PRIMAXIN IV 250/250 ADD-VANTAGE VIAL
PRIMAXIN IV 250/250 ADD-VANTAGE VIAL
Discontinued
DIN Number
01911430
Drug Class
Human
Market Date
Dec 31, 1991
Company
HC
merck frosst canada & cie, merck frosst canada & co.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01911430
AIG Number0218820002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DH51 IMIPENEM AND CILASTATIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.07.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
CILASTATIN (CILASTATIN SODIUM)Active
Strength: 250 MG / VIAL
Monograph: CILASTATIN (CILASTATIN SODIUM)
IMIPENEMActive
Strength: 250 MG / VIAL
Monograph: IMIPENEM